VALANX Biotech
Superpowering proteins
Operating in industrial research tools based in Austria, VALANX Biotech was founded in 2017.
Profile
Valanx Biotech is a university spin-out offering a patented method for high-efficiency protein conjugation for cancer drug targeting and other uses. Through the power of synthetic biology and genetic-code expansion, we have developed a novel site-specific protein conjugation platform that allows precise control over a conjugation site and the number of conjugations on the protein of interest.
Its activity falls under industrial research tools; the profile below is assembled from public directory data.
The company is recorded as being based in Austria.
The company is listed at the SOSV portfolio company stage of development.
Its team size is recorded as 2-10 employees.
It has disclosed roughly $23K in funding.
| Sector | Industrial Research Tools |
|---|---|
| Country | Austria |
| Founded | 2017 |
| Employees | 2-10 |
| Stage | SOSV portfolio company |
| Total funding | $230,000 |
Website: valanx.bio
Browse related
Create a free account